Seoul Yes Bio
A biotech company researching for a healthy future by leveraging biotechnology and medicine centered on advanced regenerative medicine.
Key Research Areas

NK Cell
Research on NK cells and the immune system

NK Plus
Immune cell activation research
(Synergy between NK cells and anticancer drugs)
Seoul Yes Bio Cell Banking Facility
Cell Storage
Immune cells and stem cells are separated from collected blood and adipose tissue, then cryopreserved through a controlled storage process.

Blood and Tissue Collection

Cell Separation Process

Cell Freezing Preparation

Cell Freezing
Healthy Time Banking
Storing strong, highly active cells
means preserving your healthy time.Stem Cell Insurance
Storing young, healthy cells is
the most effective personalized bio-insurance.Optimal Anti-Aging
A personalized anti-aging program
that uses cells in diverse ways.
NULOOK
NULOOK is a medical anti-aging and aesthetic specialty clinic established in Bali, Indonesia (Kuta, Legian) by Daewoong Pharmaceutical & CG BIO.
NULOOK Anti-Aging Regenerative Medicine
In collaboration with E:UM Healthcare at Seoul Yes Hospital, NULOOK provides stem cell and immune cell therapy, skin regeneration therapy, and anti-aging medicine.
E:UM Healthcare dispatches and trains Korean medical teams while conducting regenerative medicine research and development.
Stem Cells (UC-MSC, AD-MSC)

Stem Cells 
IV Injection (Regenerative Therapy) Immune Cells (NK CELL)

Immune Cells 
IV Injection (Immune Therapy) SVF

Stromal Vascular Fraction (SVF) 
Direct Injection into the Lesion EVs (Exosome, Secretome)

Exosomes / Secretome 
Skin Procedures and Injections
A Symbol of Anti-Aging and Healing
NULOOK CLINIC


Ginza ODA CLINIC
Located in the heart of Tokyo's Ginza, Ginza ODA CLINIC is a regenerative medicine institution licensed by Japan's Ministry of Health, Labour and Welfare, featuring a 150-pyeong treatment facility and 100-pyeong advanced research laboratory.
A Center of Advanced Regenerative Medicine in Japan
Ginza ODA Clinic
Led by Director Harunori Oda, who has 30 years of experience in regenerative medicine research,
the clinic welcomes more than 18,000 international patients each year.



Medical Team

Director Harunori Oda
- Director, Ginza ODA CLINIC
- Chairman, Ijinkai Medical Corporation
- Ginza ODA CLINIC
- Shinjuku ODA CLINIC
- Osaka ODA CLINIC
- Recipient of the 2025 Next Era Medical Leaders Award
- Honorary Director, Hainan Boao International Hospital, China

Director Eiko Omichi
- Director, Ginza ODA CLINIC
- ODA Immuno Bio Laboratory
- Director of International Medical Services, Ijinkai Medical Corporation
- International Center for Molecular Cellular Immunology, Tokyo Women's Medical University
- Research on clinical applications of immune cells, stem cell culture, and related technologies

Director Xia Ling
- Director, ODA Immuno Bio Laboratory
- Member, Certified Committee for Regenerative Medicine, Ijinkai Medical Corporation
- Postdoctoral Researcher in Biochemistry, Kumamoto University Faculty of Medicine
- Professor of Pathology, Guilin Medical University Hospital, China
- Visiting Professor, University of Turin, Italy
- Member, Japanese Society for Regenerative Medicine
- Ph.D. in Pathology, Kumamoto University School of Medicine
Reclaim Youth and Vitality from Your Cells